Table of Contents
| << Previous Issue | Jul/Aug/Sep 2010 (Vol: 2010, Issue: 7) | Next Issue >> |
- Section: Distribution & Marketing
-
Arena’s Anti-Obesity Drug Gets Commercial Partner before Approval Decision
- Section: Joint Venture
-
OncoMed Pharmaceuticals and Bayer Schering Pharma Sign a Global Cancer Pact Targeting the Wnt Pathway
-
Neurocrine Improves Financial Position by Partnering with Abbott and Boehringer Ingelheim
- Section: Licensing
-
J&J In-Licenses Twice in Diabetes
-
Sanofi-aventis Advances Diabetes Pipeline
-
Infinity Licenses Intellikine’s Oral PI3K Therapies for Oncology and Inflammatory Diseases
-
Sanofi-aventis Expands its Early-Stage Pipeline
-
Biogen Idec Expands its Portfolio with ALS Drug Candidate
- Section: Mergers & Acquisitions
-
Celgene Acquires Abraxis BioScience to Broaden its Focus in Oncology
-
Gilead Sciences Diversifies into Kinase Biology
-
Sanofi-aventis Acquires TargeGen to Strengthen its Oncology Pipeline
-
Actelion Acquires Option to Buy CNS Drug Developer Trophos
-
Shire to Acquire Movetis and Expand its Gastrointestinal Portfolio
-
Biovail Takes Over Valeant via Reverse Merger to Expand Business Model
-
Eli Lilly Acquires Alnara Pharmaceuticals for Liprotamase
-
Orchid Buys Karalex Pharma for Generics Marketing Presence in the US
-
Endo Pharmaceuticals Drives Growth in Pain Management with Acquisition of Penwest
-
GlaxoSmithKline Advances Sales Growth in Latin America with Acquisition of Laboratorios Phoenix
-
Medco Acquires United BioSource for Post-Approval Research Capabilities
-
Life Technologies Gets New DNA Sequencing Technology with Ion Torrent Acquisition
-
Aspen Pharmacare Bids for Sigma’s Pharmaceuticals Division
-
Emergent BioSolutions Looks beyond Biodefence with Trubion Acquisition
- Section: Research & Development
-
Sanofi-aventis Forms microRNA Alliance with Regulus Therapeutics
-
Novartis Validates Adimab’s Antibody Discovery Technology
-
Merck and Alectos Therapeutics to Identify and Develop Novel Drugs for Alzheimer’s Disease
RSS